News & Trends - Pharmaceuticals
Sustainable Pharma companies outperform peers
![Pharma News - Sustainable Pharma companies outperform peers](https://www.healthindustryhub.com.au/wp-content/uploads/2021/02/Sustainability.png)
Pharma News: Only four global pharmaceutical companies rank in the 2021 Global 100 Most Sustainable Corporations – Eisai, AstraZeneca, Takeda and Sanofi.
The Global 100 index evaluates the sustainability of more than 8,000 of the world’s major corporations based on various corporate initiatives in areas such as ESG (environment, society and governance).
Ranked 16th, Eisai was the highest ranking company among global pharmaceutical companies.
Takeda is proud to be ranked in the Global 100 index for the fifth consecutive year.
“Building sustainable value is a fundamental part of the way we do business at Takeda, and we are proud to be recognized as a global leader in sustainability,” said Christophe Weber, Takeda President and CEO. “This recognition by Corporate Knights is a testament to the strong foundation Takeda has laid and the progress we have already achieved. We remain steadfast in our commitment to realizing Better Health and a Brighter Future for all.”
Despite the economic impact of the COVID-19 crisis, governments around the world have seized on the opportunity presented by the need to kick-start their economies and add green investments into their stimulus plans.
The Global 100 index continues to demonstrate that sustainability is good business and enables companies to outperform their peers.
From its inception on February 1, 2005, to December 31, 2020, the Global 100 index has generated a total return of 263% versus the 220% increase of its benchmark, the MSCI ACWI (All Country World Index). For the calendar year 2020, the Global 100 was up 26% compared with a rise of 16% for the MSCI ACWI.
Global 100 companies are also more gender-diverse than their peers, with almost a third of board directors (32%) being non-male against 24% for MSCI ACWI companies.
Sustainability is now central to doing business, as the Global 100’s continuing superior performance highlights.
News & Trends - Biotechnology
![Aussie biotech secures agreement with UQ and USyd to advance cardiovascular diseases research](https://www.healthindustryhub.com.au/wp-content/uploads/2024/07/Aussie-biotech-secures-agreement-with-UQ-and-USyd-to-advance-cardiovascular-diseases-research.png)
Aussie biotech secures agreement with UQ and USyd to advance cardiovascular diseases research
Biotech News: Australian biotechnology company, Cartherics, developing immune cell therapies for the treatment of cancer, has entered into a Technology […]
MoreNews & Trends - MedTech & Diagnostics
![NSW Health Secretary urges more focus on patient experience, drawing from her own heart valve disease journey](https://www.healthindustryhub.com.au/wp-content/uploads/2024/07/NSW-Health-Secretary-urges-more-focus-on-patient-experience-drawing-from-her-own-heart-valve-disease-journey.png)
NSW Health Secretary urges more focus on patient experience, drawing from her own heart valve disease journey
In a heart-warming event that united patients, their loved ones, representatives from patient organisations and employees, Edwards Lifesciences hosted its […]
MoreHuman Resources
!['To be an inclusive society, we need an embedded national strategy to combat systemic racism', says Commissioner Sivaraman](https://www.healthindustryhub.com.au/wp-content/uploads/2024/07/To-be-an-inclusive-society-we-need-an-embedded-national-strategy-to-combat-systemic-racism-says-Commissioner-Sivaraman.png)
‘To be an inclusive society, we need an embedded national strategy to combat systemic racism’, says Commissioner Sivaraman
Race Discrimination Commissioner Giridharan Sivaraman has welcomed the release of the Multicultural Framework Review by the Federal Government, calling it […]
MoreNews & Trends - Pharmaceuticals
![New shingles vaccine is linked with lower risk of dementia](https://www.healthindustryhub.com.au/wp-content/uploads/2024/07/New-shingles-vaccine-is-linked-with-lower-risk-of-dementia.png)
Shingles vaccine lowers risk of dementia
Pharma News: A recombinant shingles vaccine which was added to Australia’s National Immunisation Program (NIP) in November last year, is […]
More